Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine inhaler receives marketing authorisation
"Treating severe equine asthma can be challenging for veterinarians and horse owners" - Erich Schoett.

Aservo Equihaler® will be available for EU distribution in 2020

A novel equine inhaler set to benefit horses suffering from severe equine asthma has been granted marketing approval by the European Commission.


Marking an industry-first in equine medicine, the Aservo Equihaler® is the culmination of more than a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. It is expected to be available for veterinary surgeons in the EU in 2020.


The inhaler incorporates a unique Soft Mist Technology®, found in the human Respimat® inhaler. This allows the active ingredient - ciclesonide - to be inhaled deep into the lung, thereby reducing the risk of lower airway inflammation.

Designed specifically for horses, the inhaler also features an ergonomic handle, dosing lever for ease of handling and a nostril adaptor that fits inside the nostril of the horse to allow for easy inhalation.

Erich Schoett, global business head of equine for the Boehringer Ingelheim Animal Health Business Unit, said: “Treating severe equine asthma can be challenging for veterinarians and horse owners, who struggle to find safe and effective ways to help horses breathe.


“Bringing a new, safe and effective treatment to the market is something that we can really be proud of. It is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.”

Become a member or log in to add this story to your CPD history

BEVA gives vets access to free membership for three months

News Story 1
 BEVA has announced that it is cutting membership renewal charges for the next three months in order to support all veterinary professionals during the COVID-19 pandemic.

Memberships for all existing BEVA members will be extended until 30 June 2020. Veterinary professionals who are not members of BEVA will also be able to sign up for a free membership until 30 June 2020.

BEVA president Tim Mair said: "In this extraordinary time of global crisis our profession, as with many industries, is under immense pressure. By offering free membership we are giving equine vets easy access to a wealth of supportive resources and online CPD."

To sign up please visit the BEVA website.

Image (c) BEVA. 

Click here for more...
News Shorts
BSAVA rolls out CPD resources and benefits in absence of Congress

A package of CPD resources and benefits are set to be rolled out on BSAVA's social media channels over the coming days in a bid to fill the gap left by the cancellation of BSAVA Congress.

The package includes a 10 discount voucher on all printed manuals and access to the BSAVA Library. BSAVA said that it will also be recording more than 100 hours of planned Congress lectures over the following weeks so that vets don't completely miss out on the Congress experience.

The resource, titled Congress on Demand will be ready in early May.